Modular Medical Announces Proposed Public Offering SAN DIEGO, CA/ACCESSWIRE/

Modular Medical Announces Proposed Public Offering

SAN DIEGO, CA/ACCESSWIRE/ December 9, 2025 --

Modular Medical, Inc. (Nasdaq: MODD) ("Modular Medical"), an insulin delivery technology company with the first FDA-cleared

patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today

announced that it has commenced an underwritten public offering (the "offering") of shares of its common stock and warrants

to purchase shares of its common stock. The shares of the common stock and the accompanying warrants are immediately separable and will

be issued separately but can only be purchased together in this offering.

Modular Medical expects to grant the underwriter

a 30-day option to purchase up to an additional 15% of the aggregate number of shares of its common stock and /or warrants sold in the

offering. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may

be completed or as to the actual size or terms of the offering. All shares of common stock and warrants to be sold in the proposed offering

will be sold by Modular Medical.

Newbridge Securities Corporation is acting as

the sole bookrunner for the proposed offering.

The offering is being made pursuant to an effective

"shelf" registration statement on Form S-3 (File No. 333-287313) previously filed with the Securities and Exchange Commission

(the "SEC") on May 15, 2025 and declared effective by the SEC on May 22, 2025. The securities may be offered only by means

of a prospectus. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering

will be filed with the SEC. Electronic copies of the preliminary prospectus supplement and accompanying prospectus and, when available,

copies of the final prospectus supplement and the accompanying prospectus relating to the offering may be obtained by visiting the SEC's

website at www.sec.gov or by contacting Newbridge Securities Corporation, Attn: Equity Syndicate Department, 1200 North Federal Highway,

Suite 400, Boca Raton, Florida 33432, by email at syndicate@newbridgesecurities.com

or by telephone at (877) 447-9625.

This press release does not constitute an offer

to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other

jurisdiction in which such offer, solicitation, or sale would be unlawful prior to the registration or qualification under the securities

laws of any such state or jurisdiction.

About Modular Medical

Modular Medical, Inc. (Nasdaq: MODD) is a medical

device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company

seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple

to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes, taking it beyond "superusers"

and providing "diabetes care for the rest of us."

Modular Medical was founded by Paul DiPerna, a

seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005)

of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.

All trademarks mentioned herein are the property

of their respective owners.

Forward-Looking Statements

This press release contains forward-looking statements

that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements

can be identified through the use of words such as "may," "might," "will," "intend," "should,"

"could," "can," "would," "continue," "expect," "believe," "anticipate,"

"estimate," "predict," "outlook," "potential," "plan," "seek,"

and similar expressions and variations or the negatives of these terms or other comparable terminology. Such forward-looking statements

are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements

contained in this press release, including whether or when the offering may be completed, as well as other risk factors and business considerations

described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press

release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press

release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its

views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required

Chief Executive Officer

Modular Medical, Inc.